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David R. Holmes, JR, MD, Charanjit S. Rihal, MDSEE PAGE 875A nalogous to transcatheter aortic valvereplacement, the assessment and treatmentof mitral insufﬁciency have assumed more
central importance, primarily driven by 4 major fac-
tors: 1) The recognition that the disease is complex,
consisting of multiple interrelated anatomic and
physiological issues; 2) the expanding knowledge
that the mortality and morbidity risk in some of these
patients is high, often resulting from associated
comorbidities; 3) the fact that surgical treatment for
this complex group of problems is not ideal in many
patients, because some patients are at high risk,
with some cases even deemed to have prohibitive
surgical risk or to be inoperable; and 4) the prolifera-
tion of technology aimed at addressing the issues
using less invasive catheter-based approaches.
When one considers these issues, it must be remem-
bered (or perhaps, more accurately, learned) that
mitral regurgitation (MR) is based on a complex set
of interrelationships. These anatomic factors include
the speciﬁc anatomy of the mitral valve, mitral
annular, and subvalvular apparatus, such as impor-
tant chordal structures, as well as regional and global
left ventricular function. These anatomic relation-
ships are in turn affected by physiological perturba-
tions, including ventricular and annular dilation in
response to volume and pressure overload on top of
prior myocardial injury. Finally, the relationships
between the mitral valve and closely surrounding
structures, such as the circumﬂex coronary artery,
must be kept in mind. These relationships have
led to a broad grouping as functional MR versus
degenerative MR. However, such groupings, although
discrete and dichotomous, do not fully explain the
number and overlap of the variables involved.*Editorials published in the Journal of the American College of Cardiology
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apparent that 1 size for transcatheter repair or re-
placement will never ﬁt all. That tenet is an essential
component of the development of multiple new
technological strategies.In this issue of the Journal, Nickenig et al. (1)
summarize experience with a speciﬁc technology
(MitraClip, Abbott Vascular, Santa Clara, California),
which has been studied widely and is now approved
in both the European Union and the United States.
This technology has been used in approximately
15,000 patients worldwide and has been the subject
of small, carefully designed, randomized clinical
trials and larger registries. The speciﬁc technology is
based on Alﬁeri’s surgical approach, which results in
“snake eyes,” or a double-inlet mitral valve. The
Sentinel Registry of Percutaneous Edge-to-Edge
Mitral Valve Repair ﬁlls gaps in the knowledge base,
evaluating the technology in a multinational environ-
ment of 8 countries, 25 centers, and 628 patients. It
does not, however, afford the reader the chance of
having the full denominator of the entire set of expe-
riences in Europe, nor does it offer a glimpse of what
carefully adjudicated data by central laboratories
might provide; having said that, however, it is a
wonderful source of data.
There are several bottom lines. First, patients
treated with this technology are elderly, highly
symptomatic, and have a high logistic EuroSCORE
(European System for Cardiac Operative Risk Evalu-
ation; 20.4  16.7%). These are not the sort of patients
for whom there is a long roster of cardiovascular
surgeons waiting outside the room to talk about
scheduling for a surgical date.
Second, the most prevalent pathogenesis was
functional MR, seen in 72%, whereas the remainder
had degenerative MR.
Third, acute procedural success was excellent at
95.4%. Of great interest, there was no difference in
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886procedural success between functional and degener-
ative MR cases. As part of this procedural success,
1 clip was implanted in 61% of the patients, whereas
the remainder had more than 1 device implanted.
Fourth, in-hospital mortality was low at 2.9%,
again without differences between those patients
being treated for functional MR and those treated
for degenerative MR. However, mortality increased
dramatically to 15.3% at 1 year, which reﬂects the
patient’s comorbid status.
Fifth, there was a dramatic reduction in the degree
of MR during the procedure. At baseline for the entire
group, 13.2% and 86.1%, respectively, had either
moderate or severe MR, whereas immediately after-
ward, that had been reduced to 25.4% and 1.8%,
respectively. This reduction persisted at 1 year in a
subset of paired clinical study readings, which docu-
mented that only 6% had severe MR at that time.
Despite this improvement, the estimated rate of
rehospitalization for the entire group was 22.8%.
Sixth, there was a signiﬁcant improvement in New
York Heart Association functional class. This has been
seen in other studies, along with improvement in
quality-of-life indicators. These improvements in this
elderly, frail group of patients make a marked dif-
ference in their life. Importantly, we need to bear in
mind that most invasive treatments in medicine (e.g.,
procedures such as knee replacements) are performed
to improve quality of life and functional status, and
that is arguably the greatest goal of technology.
There are several very important areas that need to
be addressed in the ﬁeld.
First, the procedure is complex, requiring very
close coordination between echocardiography, inter-
ventional cardiology, and cardiovascular surgery. As
noted by Nickenig et al. (1), in 39% of patients, a
second clip was needed. Detailed knowledge of
3-dimensional anatomy, including the atrial septum
and the mitral apparatus, to optimize reduction in MR
is required. In general, in the published literature,
reduction in severity of MR is greater in patients
treated with cardiovascular surgery, but the patients
in whom transcatheter mitral valve repair (TMVR) isintended are at increased risk for surgery. Profes-
sional societies need to continue to deﬁne parameters
of experience for individual operators and in-
stitutions to qualify for procedural performance.
Training programs will continue to evolve and include
simulation models, exposure to anatomic specimens,
and often proctored cases. All of these elements will
combine to optimize the outcome of the procedure.
Next, patient selection criteria continue to evolve.
As previously mentioned, MR has been divided into
2 broad groups, degenerative and functional. At the
present time, TMVR is approved in the United States
for patients with signiﬁcant degenerative MR who are
at high risk for surgery. As described in the article
by Nickenig et al. (1), the dominant problem treated
was functional MR. There were some differences
in outcome. Patients with functional MR required
signiﬁcantly more rehospitalizations. There were also
differences in the severity of MR, change in left atrial
size, and nonsigniﬁcant changes in left ventricular
ejection fraction between the 2 groups. The extent to
which these changes will help to guide patient
selection is unclear. More data will be needed.
Finally, the potential concern that placement of 1
or more clips may make subsequent procedures more
difﬁcult is important. In small experiences reported
to date, surgery can still be performed, if needed,
after a MitraClip has been placed. If more than 1
clip has been used initially, subsequent surgical ap-
proaches may be more difﬁcult.
This multicenter registry experience is an example
of the strength of registries in evaluating the appli-
cation in broader patient groups. Such an approach
may serve as a template in selected circumstances
for post-market approval studies, which are critical
to understanding outcomes with the use of new
technologies.
REPRINT REQUESTS AND CORRESPONDENCE: Dr.
David R. Holmes, Jr., Mayo Clinic, Cardiovascular
Diseases and Internal Medicine, 200 First Street, SW,
MB 4-523, Rochester, Minnesota 55905. E-mail: holmes.
david@mayo.edu.RE F E RENCE1. Nickenig G, Estevez-Loureiro R, Franzen O,
et al. Percutaneous mitral valve edge-to-edge
repair: in-hospital results and 1-year follow-upof 628 patients of the 2011-2012 Pilot European
Sentinel Registry. J Am Coll Cardiol 2014;64:
875–84.KEY WORDS functional versus degenerative
mitral regurgitation, mitral regurgitation,
percutaneous mitral valve repair
